Alexis Rovner is the founder of 64x Bio. 64x Bio has raised $55M in total funding. Latest round: Series A. Based in San Francisco, CA.
Alexis "Lex" Rovner is the CEO & co-founder of 64x Bio, a synthetic biology company based in San Francisco. The company focuses on advancing its VectorSelect™ platform, a cell line engineering technology designed to revolutionize gene therapy manufacturing by addressing critical bottlenecks. In January 2022, 64x Bio closed a $55 million Series A financing round led by Lifeforce Capital.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide